首页> 美国卫生研究院文献>Pulmonary Circulation >Safety of cardiac catheterization at a center specializing in the care of patients with pulmonary arterial hypertension
【2h】

Safety of cardiac catheterization at a center specializing in the care of patients with pulmonary arterial hypertension

机译:在专为肺动脉高压患者提供护理的中心进行心脏导管插入术的安全性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cardiac catheterization is important for the management of patients with pulmonary arterial hypertension (PAH). It is used for diagnosis, assessment, and monitoring of PAH patients, as well as to perform interventions such as balloon atrial septostomy and coil embolization of collateral vessels. Although reports on the risks of catheterization in PAH patients are scarce, many centers hesitate to perform these procedures in such fragile patients. We performed a retrospective chart review of all cardiac catheterizations performed in PAH patients over 10 years at our pulmonary hypertension center. Demographic, hemodynamic, and outcome data were collected. Complication rates were determined, and multivariate proportional hazards modeling was performed to identify predictors of catheterization-related complications. There were 1,637 catheterizations performed in 607 patients over 10 years. Pediatric patients accounted for 50% of these cases, 48% were performed in patients with idiopathic PAH, and 49% were performed under general anesthesia. While the overall complication rate was 5.7%, the rate of major complications was only 1.2% (). Although there were 8 deaths during the admission following catheterization, only 4 of these were related to the procedure, yielding a catheterization-related mortality of 0.2%. In conclusion, when performed at a pulmonary hypertension center with expertise in the care of PAH patients, cardiac catheterization is associated with low complication rates and mortality, and it should remain an important tool in the management of these patients.
机译:心脏导管插入术对肺动脉高压(PAH)患者的治疗很重要。它用于PAH患者的诊断,评估和监视,以及执行诸如球囊房造瘘术和侧支血管盘塞术等干预措施。尽管很少有关于PAH患者导管插入风险的报道,但许多中心对这类脆弱的患者不愿进行这些操作。我们对肺动脉高压中心超过10年的PAH患者进行的所有心脏导管检查进行了回顾性图表审查。收集人口统计学,血液动力学和结局数据。确定并发症发生率,并进行多元比例风险建模,以确定导管相关并发症的预测因素。在10年中,有607例患者进行了1637例导管插入术。小儿患者占这些病例的50%,特发性PAH患者占48%,全身麻醉占49%。总体并发症发生率为5.7%,而主要并发症的发生率仅为1.2%()。尽管导尿后入院期间有8例死亡,但其中只有4例与手术有关,导尿相关的死亡率为0.2%。总之,当在具有PAH患者护理专业知识的肺动脉高压中心进行心脏导管插入术时,其并发症发生率和死亡率较低,因此,导管插入术仍应是这些患者管理的重要工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号